AOD-9604 5mg

AOD 9604 5mg — Proven HGH-Derived Lipolytic Research Peptide

AOD 9604 5mg is a structurally modified fragment derived from human growth hormone (HGH) residues 176–191, developed during the late 1990s as a targeted lipolytic research compound. Supplied as a lyophilised white powder in a single 5mg vial with a verified purity of ≥98%, this peptide is formulated to the precise standards required for in-vitro scientific investigation.

⚠️ Research Use Only. This product is intended exclusively for in-vitro scientific research. It is not approved for human or animal consumption, clinical use, or therapeutic application.

Table of Contents

1. Product Specifications
2. Mechanism of Action
3. Research Applications
4. Reconstitution and Storage
5. FAQ

Product Specifications

Mechanism of Action

AOD9604 5mg is derived from the C-terminal fragment of human growth hormone — specifically residues 176 to 191. This region of HGH has been identified in research as the segment responsible for the hormone’s lipolytic activity, isolated and modified to function independently of the growth-promoting properties of full-length HGH.

The primary mechanism under investigation is the peptide’s apparent ability to stimulate the breakdown of fat stores — a process termed lipolysis — while simultaneously inhibiting lipogenesis, the formation of new fat tissue. Critically, research to date has not identified significant effects on blood glucose levels or abnormal growth activity, distinguishing this fragment from full HGH in terms of its metabolic selectivity.

The precise molecular mechanism by which aod 9604 for sale in research contexts exerts its lipolytic activity remains an active area of investigation. Current hypotheses centre on interactions with beta-adrenergic receptors and downstream signalling pathways involved in adipocyte metabolism.

Beyond its primary lipolytic research application, AOD-9604 has demonstrated several apparently independent areas of research interest — including cartilage regeneration, metabolic improvement and cardiovascular activity markers, as observed in preclinical and early clinical studies.

Research Applications

AOD-9604 is actively investigated across several research domains:

• Adipose tissue metabolism and lipolysis studies
• Lipogenesis inhibition research
• Obesity and metabolic syndrome investigation
• Cartilage and connective tissue regeneration studies
• Cardiovascular metabolic marker research
• HGH fragment pharmacology and receptor binding studies

All research is conducted within approved in-vitro and preclinical frameworks. This compound is not approved for therapeutic use.

Reconstitution and Storage

Reconstitute with sterile or bacteriostatic water at 2.5ml per vial. Add solvent slowly along the vial wall and allow to dissolve by gentle rotation. Do not shake or vortex.

Store lyophilised powder at −20°C. Once reconstituted, maintain at 4°C and use within the recommended timeframe for your research protocol. Protect from direct light and avoid repeated freeze-thaw cycles.

Explore additional research-grade peptides in our Weight Loss, Longevity and Anti-Age and Healing research categories.

FAQ

What is AOD 9604 5mg? AOD 9604 5mg is a modified fragment of human growth hormone derived from HGH residues 176–191. It is a lipolytic research peptide primarily investigated for its potential to stimulate fat breakdown and inhibit fat formation in research models. Supplied as a lyophilised white powder with ≥98% purity, it is intended exclusively for in-vitro scientific research.

How does AOD9604 5mg differ from full HGH? AOD9604 5mg is isolated from the C-terminal region of HGH — specifically the fragment associated with lipolytic activity — and does not carry the growth-promoting properties of full-length human growth hormone. Research to date has not identified the blood glucose alterations or abnormal growth activity associated with full HGH, making it a structurally and pharmacologically distinct research compound.

What is AOD 9604 5mg reconstitution procedure? For in-vitro research applications, AOD 9604 5mg reconstitution is performed by adding 2.5ml of sterile or bacteriostatic water per vial. Introduce solvent slowly along the vial wall and allow the lyophilised powder to dissolve by gentle rotation. Do not apply heat or mechanical agitation. Store reconstituted solution at 4°C and protect from light exposure.

How is AOD 9604 used in research? AOD 9604 how to use in research contexts involves reconstituting the lyophilised peptide as specified above and applying the resulting solution within the parameters of approved in-vitro assays. Research applications include receptor-ligand binding studies, cell proliferation assays, enzyme activity investigations and cell signalling analyses. This compound is not approved for human administration.

Is AOD 9604 for sale for human use? AOD 9604 for sale through this platform is supplied strictly for in-vitro scientific research purposes. It is not approved for human consumption, therapeutic use, or administration as a supplement, drug or food product. Researchers requiring this compound for approved in-vitro studies should ensure compliance with all applicable institutional and regulatory requirements.